SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ruth Hornedo-Ortega, Ana B. Cerezo, Ana M. Troncoso, M. Carmen Garcia-Parrilla, Albert Mas, Melatonin and Other Tryptophan Metabolites Produced by Yeasts: Implications in Cardiovascular and Neurodegenerative Diseases, Frontiers in Microbiology, 2016, 6,

    CrossRef

  2. 2
    Natalia A. Stefanova, Kseniya Y. Maksimova, Elena Kiseleva, Ekaterina A. Rudnitskaya, Natalia A. Muraleva, Nataliya G. Kolosova, Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of Alzheimer's disease-like pathology, Journal of Pineal Research, 2015, 59, 2
  3. 3
    G. O’Neal-Moffitt, V. Delic, P. C. Bradshaw, J. Olcese, Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPPswe/PS1 mice, Molecular Neurodegeneration, 2015, 10, 1

    CrossRef

  4. 4
    Liang Schweizer, Luciano Mueller, Biased Signaling in Physiology, Pharmacology and Therapeutics, 2014,

    CrossRef

  5. 5
    Sergio A. Rosales-Corral, Russel J. Reiter, Dun-Xian Tan, Lucien C. Manchester, Xiaoyan Liu, Aging, 2014,

    CrossRef

  6. 6
    Pingping He, Xinping Ouyang, Shouhong Zhou, Weidong Yin, Chaoke Tang, Moshe Laudon, Shaowen Tian, A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease, Hormones and Behavior, 2013, 64, 1, 1

    CrossRef

  7. 7
    L.A. Woods, S.E. Radford, A.E. Ashcroft, Advances in ion mobility spectrometry–mass spectrometry reveal key insights into amyloid assembly, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2013, 1834, 6, 1257

    CrossRef

  8. 8
    Li Lin, Qiong-Xia Huang, Shu-Sheng Yang, Jiang Chu, Jian-Zhi Wang, Qing Tian, Melatonin in Alzheimer’s Disease, International Journal of Molecular Sciences, 2013, 14, 7, 14575

    CrossRef

  9. 9
    Cheng Ni, Gang Tan, Ailun Luo, Min Qian, Yi Tang, Yang Zhou, Jun Wang, Min Li, Yan Zhang, Donglin Jia, Changyi Wu, Xiangyang Guo, Melatonin Premedication Attenuates Isoflurane Anesthesia-Induced β-Amyloid Generation and Cholinergic Dysfunction in the Hippocampus of Aged Rats, International Journal of Neuroscience, 2013, 123, 4, 213

    CrossRef

  10. 10
    Sergio A. Rosales-Corral, Dario Acuña-Castroviejo, Ana Coto-Montes, Jose A. Boga, Lucien C. Manchester, Lorena Fuentes-Broto, Ahmet Korkmaz, Shuran Ma, Dun- Xian Tan, Russel J. Reiter, Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin, Journal of Pineal Research, 2012, 52, 2
  11. 11
    Study on the noncovalent interactions of antiepileptic drugs and amyloid β 1-40 peptide by electrospray ionization mass spectrometry, Rapid Communications in Mass Spectrometry, 2012, 26, 19
  12. 12
    Giuseppe Grasso, The use of mass spectrometry to study amyloid-β peptides, Mass Spectrometry Reviews, 2011, 30, 3
  13. 13
    Juliana Bender Hoppe, Rudimar Luiz Frozza, Ana Paula Horn, Ricardo Argenta Comiran, Andressa Bernardi, Maria Martha Campos, Ana Maria Oliveira Battastini, Christianne Salbego, Amyloid-β neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3β, tau and neuroinflammation, Journal of Pineal Research, 2010, 48, 3
  14. 14
    Eric Martineau, Janna M. Guzman, Lioudmila Rodionova, Xianqi Kong, Paul M. Mayer, Ahmed M. Aman, Investigation of the noncovalent interactions between anti-amyloid agents and amyloid β peptides by ESI-MS, Journal of the American Society for Mass Spectrometry, 2010, 21, 9, 1506

    CrossRef

  15. 15
    Haipeng Song, Sandra Ritz, Wolfgang Knoll, Eva-Kathrin Sinner, Conformation and topology of amyloid β-protein adsorbed on a tethered artificial membrane probed by surface plasmon field-enhanced fluorescence spectroscopy, Journal of Structural Biology, 2009, 168, 1, 117

    CrossRef

  16. 16
    Dimitra Benaki, Konstantina Stathopoulou, Leondios Leondiadis, Nikolaos Ferderigos, Maria Pelecanou, Emmanuel Mikros, Detection of interactions of the β-amyloid peptide with small molecules employing transferred NOEs, Journal of Peptide Science, 2009, 15, 6
  17. 17
    Zoreh Davanipour, Eugene Sobel, Long-term exposure to magnetic fields and the risks of Alzheimer's disease and breast cancer: Further biological research, Pathophysiology, 2009, 16, 2-3, 149

    CrossRef

  18. 18
    James M. Olcese, Chuanhai Cao, Takashi Mori, Malgorzata B. Mamcarz, Anne Maxwell, Melissa J. Runfeldt, Li Wang, Chi Zhang, Xiaoyang Lin, Guixin Zhang, Gary W. Arendash, Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease, Journal of Pineal Research, 2009, 47, 1
  19. 19
    Haiyun Xu, Haitao Wang, Lixia Zhuang, Bin Yan, Yingxin Yu, Zelan Wei, Yanbo Zhang, Lillian E. Dyck, Steven J. Richardson, Jue He, Xiaokun Li, Jiming Kong, Xin-Min Li, Demonstration of an anti-oxidative stress mechanism of quetiapine, The FEBS Journal, 2008, 275, 14
  20. 20
    Masilamoni J. Gunasingh, Jesudason E. Philip, Ben S. Ashok, R. Kirubagaran, W. Charles E. Jebaraj, G. Dicky John Davis, S. Vignesh, S. Dhandayuthapani, R. Jayakumar, Melatonin prevents amyloid protofibrillar induced oxidative imbalance and biogenic amine catabolism, Life Sciences, 2008, 83, 3-4, 96

    CrossRef

  21. 21
    Manuela Bartolini, Carlo Bertucci, Maria Laura Bolognesi, Andrea Cavalli, Carlo Melchiorre, Vincenza Andrisano, Insight Into the Kinetic of Amyloid β (1–42) Peptide Self-Aggregation: Elucidation of Inhibitors’ Mechanism of Action, ChemBioChem, 2007, 8, 17
  22. 22
    Jian-zhi WANG, Ze-fen WANG, Role of melatonin in Alzheimer-like neurodegeneration, Acta Pharmacologica Sinica, 2006, 27, 1
  23. 23
    Alessandra Di Tullio, Samantha Reale, Francesco De Angelis, Molecular recognition by mass spectrometry, Journal of Mass Spectrometry, 2005, 40, 7
  24. 24
    Fotini N. Bazoti, Anthony Tsarbopoulos, Karin E. Markides, Jonas Bergquist, Study of the non-covalent interaction between amyloid-β-peptide and melatonin using electrospray ionization mass spectrometry, Journal of Mass Spectrometry, 2005, 40, 2
  25. 25
    Qing Zeng, Qiang Yin, Yufen Zhao, The study on the interaction between seryl-histidine dipeptide and proteins by circular dichroism and molecular modeling, Bioorganic & Medicinal Chemistry, 2005, 13, 7, 2679

    CrossRef

  26. 26
    Vlada A. Pashynska, Hilde Heuvel, Magda Claeys, Marina V. Kosevich, Characterization of noncovalent complexes of antimalarial agents of the artemisinin-type and Fe(III)-heme by electrospray mass spectrometry and collisional activation tandem mass spectrometry, Journal of the American Society for Mass Spectrometry, 2004, 15, 8, 1181

    CrossRef

  27. 27
    Jeong Eun Kim, Minyung Lee, Fullerene inhibits β-amyloid peptide aggregation, Biochemical and Biophysical Research Communications, 2003, 303, 2, 576

    CrossRef

  28. 28
    Séverine Zirah, Sylvie Rebuffat, Sergey A Kozin, Pascale Debey, Françoise Fournier, Denis Lesage, Jean-Claude Tabet, Zinc binding properties of the amyloid fragment Aβ(1–16) studied by electrospray-ionization mass spectrometry, International Journal of Mass Spectrometry, 2003, 228, 2-3, 999

    CrossRef

  29. 29
    Lukasz P. Frankiewicz, Karolina Pulka, Andrzej W. Lipkowski, Aleksandra Misicka, Cross interaction of β-amyloid peptide and prion protein fragments, Letters in Peptide Science, 2002, 9, 2-3, 77

    CrossRef

  30. 30
    Current literature in mass spectrometry, Journal of Mass Spectrometry, 2002, 37, 1
  31. You have free access to this content31
    Michael R. D'Andrea, Daniel H.S. Lee, Hoau-Yan Wang, Robert G. Nagele, Targeting intracellular Aβ42 for Alzheimer's disease drug discovery, Drug Development Research, 2002, 56, 2
  32. 32
    Bruno P. Imbimbo, Francesca Speroni, β-Amyloid Therapeutic Strategies for Alzheimer's Disease, Burger's Medicinal Chemistry and Drug Discovery,